Abstract
|
Article Information:
Probable Cure of Two Patients With Advanced Gastric Carcinoma by Chemotherapy Only: Long-term Follow-up of a Phase I Trial With a Weekly Carboplatin and Epirubicin Regimen
E.J.M. Siemerink, G.A.P. Hospers, J.C. Berends, J.A. Gietema and N.H. Mulder
Corresponding Author: Mulder
Submitted: 2009 Month, 00
Accepted: 2009 July, 18
Published: |
Abstract:
|
A dose escalation study of carboplatin in combination with 5FU and epirubicin in surgically
incurable gastric cancer. Carboplatin was combined with a fixed dose epirubicin 35 mg/m2, leucovorin 250
mg/m2 and 5 FU 500 mg/m2 (CELF). The starting dose of carboplatin w as 100 mg/m2 which was escalated to
150 mg/m2. This CELF regimen was repeated every week, for a maximum of 14 cycles. Primary prophylaxis
against leucopenia with filgastrim w as given. Twelve chemotherapy naive patients were enrolled, 9 w ith
metastatic disease and 3 with locally advanced surgically irresectable disease. The major toxicities of the CELF
regimen were uncomplicated leucopenia and thrombopenia. Nausea and mucositis were the most common nonhematological
toxicities. The dose-limiting toxicity was grade 3 leucopenia, observed at a dose of 150
mg/m2/week. The objective response rate was 58% (95% CI 31%-85%). From the three patients with localized
but surgically incurable disease two remain alive without disease progression and without sym ptoms after 6
and 9 years after chemotherapy without any other treatment.
Key words: Stomach neoplasms, metastatic, chemotherapy, gastric, long-term survival, ,
|
Abstract
|
PDF
|
HTML |
|
Cite this Reference:
E.J.M. Siemerink, G.A.P. Hospers, J.C. Berends, J.A. Gietema and N.H. Mulder, . Probable Cure of Two Patients With Advanced Gastric Carcinoma by Chemotherapy Only: Long-term Follow-up of a Phase I Trial With a Weekly Carboplatin and Epirubicin Regimen. Asian Journal of Medical Sciences, (2): Page No: 42-46.
|
|
|
|
|
ISSN (Online): 2040-8773
ISSN (Print): 2040-8765 |
|
Information |
|
|
|
Sales & Services |
|
|
|